News
TipRanks on MSN13h
H.C. Wainwright says Capricor path to approval ‘sharpens’ with inspection doneH.C. Wainwright notes that Capricor Therapeutics (CAPR) announced that the FDA has completed its pre-license inspection of the company’s San Diego ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback